1. Targos
Biomarker Meeting 2013
February 25 – 26
Waldgut
Schloss Höhnscheid
Bad Arolsen – Höhnscheid
Germany
Targos

2. Welcometothe
TargosBiomarkerMeeting2013
February25-26,2013
WaldgutSchlossHöhnscheid,
34454BadArolsen–Höhnscheid,Germany
Agenda
Sunday,February24
11.00am–11.00pmArrivalofparticipants
6.00-9.00pmInformaldinner
Monday,February25
Moderator:
UniversityofSouthernCalifornia,LosAngeles.USA
Venue:
7.30amBreakfast
9.00amPick-up,TraveltoTargosbybus
Onbus:
IntroductionofTargosand
PathologieNordhessen
10.00amArrival-Targos
10.15–10.45amTargosfacilitytour
10.45–11.15amPathologieNordhessenfacilitytour
11.15–11.30amBREAK
11.30–12.00noonIntroductionofspeakersandindustry
participants
Targos
12.00–12.45pmLUNCH

3. 1.00–1.30pmFDAperspectiveonpredictive
biomarkers
UniversityofSouthernCalifornia
LosAngeles,USA
1.30–2.00pmPredictivebiomarkersinlymphomas
2.00–2.30pmPredictivebiomarkersinmelanoma
Center,Houston,USA
2.30–3.00pmPredictivebiomarkersinbreastcancer
3.00–3.30pmBREAK
3.30–4.00pmPredictivebiomarkersandgenomic
strategiesforrationalcombinationof
targetedtherapies
4.00–4.30pmPredictivebiomarkertestinginBrazil
4.30pmBustoWaldgutSchlossHöhnscheid
6.00–7.00pmDINNER
7.00–8.30pmDiscussionandperspectivefrom
industryparticipants
8.30pmClose-outofthedayatthefireplace
Tuesday,February26
Moderator:
Venue:WaldgutSchlossHöhnscheid
7.15–8.15amBreakfast
8.30–9.00amRoleofcentralpathologyreviewinclinical
trailsforbreastcancerpatients
9.00–9.30amPredictivebiomarkersin
colorectalcancer
9.30–10.00amPredictivebiomarkersinstomachcancer
10.00–11.00amBREAK/GroupPhoto
11.00–11.30amPredictivebiomarkersinNSCLC
11.30–12.00pmPredictivebiomarkersinSCLC/NSCLC
Germany
12.00–12.30pmPredictivebiomarkersinsarcomas
CenterGöttingen
12.30–1.30pmLUNCH
1.30–3.00pmGeneraldiscussionandwrap-upofmeeting
3.00pmCloseofthebiomarkermeeting

4. CliveRoyTaylor,MD,DPhil,MRCP(Ir),FRCPath
UniversityofSouthernCalifornia,LosAngeles.USA
-
-
-
--------------------------------------------------------
PhilippeGaulard,MD
malignancies.Hemaintainsanimportantpracticeofhematopathology
comprisingmanyconsultationcases,istheformermedicaldirectorof
-
gistsfromFranceandseveralneighbouringEuropeancountriesconduc-
lymphomaentitiesincludingprimarymediastinallargeB-celllymphoma
toimprovethediagnosisoflymphomas,andcontributetobettermanage-
-
nationalandinternationalcongresses.
--------------------------------------------------------
AlexanderLazar,MD,PhD
pathogenesis,andtargetedtherapiesforsarcoma&melanomainthe
Center.Heisinvolvedinmultiplecollaborative,laboratory-basedre-
-
-
-
-
larmodeling,heisfocusedonintegratingmolecularmarkersintocancer

5. forreportingclinicalmoleculardiagnostictestinginsolidtumors.Onthe
authoredmorethan200publicationsonnumerousaspectsofskinand
-
--------------------------------------------------------
SunilBadve,MD
SunilBadvereceivedhismedicaldegreeandpathologyresidencyatGrant
-
-
bookchapters.HeservesastheassociateeditorofClinicalBreastCancer
speakeratnationalandinternationalpathologymeetingsandhascon-
-
--------------------------------------------------------
BrianLeyland-Jones,MBBS,PhD
recentlyservedasassociatevicepresidentanddirectoroftheEmory
atMcGillUniversityinMontreal,Canada.
-
-
--------------------------------------------------------
VenancioAvanciniFerreiraAlves,MD,PhD
ofeventsfromviralhepatitisandsteato-hepatitistocirrhosistoliver

6. biomarkersusefulfordiagnosisand,morerecently,fortargetedtumor
--------------------------------------------------------
GiuseppeViale,MD,FRCPath
CollaborativeGroupSteeringCommittee,andheisFoundingMemberof
Hehasbeenactiveinclinicalandtranslationalresearchesonbreast
36chaptersinbooks
--------------------------------------------------------
BharatJasani,MBChB,PhD,FRCPath
-
-
tegicplanstomodernisehistopathologyservice,andthedevelopment
ofdiagnosticimmunocytochemistry&molecularpathologyservicein
andstandardisationofcancerbiomarkeranalysesastheBreastCancer
-
fortranslationalresearchprojectstargetedatdevelopingpredictivebio-
intra-operativemethodforsentinellymphnodebreastcancermetastases.
-
Medicine.
--------------------------------------------------------
JosefRüschoff,MD

7. -
-
CancerSociety.
Hehasparticipatedinmorethan100clinicaltrailspertainingtobreast,
-
-
-
ledtrial.
-
Heisarecipientofmanygrantsandaconsultanttosomepublic
corporations.
--------------------------------------------------------
ManuelSalto-Tellez,MD,FRCPath
andgenotypeinbothdiagnosticsandtranslationalresearch.
inmanynationalandinternationalconferences.Hisareasofdiagnosticin-
terestaregastrointestinalpathologyandmoleculardiagnosis.Hisareasof
researchinterestincludethediscoveryandvalidationofnovelmolecular
biomarkersofdisease,thevalidationandtechnologytransferofnoveldis-
coveriesintothemoleculardiagnosticpracticeandthemolecularpatho-
--------------------------------------------------------
ReinhardBüttner,MD

8. inhigh-impactjournals.Somerepresentativepublicationssince2010are;
integrativegenomeanalysesandScienceTranslMed,inpress2012;
andpubliccorporations.
--------------------------------------------------------
PhilippStröbel,MD
-
ofimatinibandsunitinibinthymiccarcinomasandco-authorshipsinmany
-
thologyattheUniversityMedicalCenterMannheim,UniversityofHeidel-
CenterGöttingen.Hismainresearchinterestsaremolecularpathology

9. JohnLowe,MD
--------------------------------------------------------
HartmutKoeppen,MD,PhD
--------------------------------------------------------
Dr.H.-J.Grote
HeadofHistopathologyinBiomarkerTechnologiesatMerckKGaA,Germany
--------------------------------------------------------
WernerKroll.GlobalHeadofResearch.MDx.
--------------------------------------------------------
PilarGarin-Chesa,MD,PhD
--------------------------------------------------------
HaraldBerninger
--------------------------------------------------------
Dr.BärbelPorstmann
--------------------------------------------------------
HenrikWinther,DVM,PhD
--------------------------------------------------------

10. AboutTargos
-
mentandapplicationofclinicalbiomarkersfortheinternationalpharma-
ceuticalanddiagnosticindustry.
Thecompanyhassupportedmorethan100internationalclinicaltrials
pathologistsisembeddedinaprofessionalenvironmentofprojectma-
-
toryimprovementprograms.
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________

11. 2011 European Frost &
Service Leadership
Targos
Germaniastrasse 7
thomas.henkel@targos-gmbh.de
Tel: +49-561-50045300